Key Metrics
CiteScore 

4
SJR 

Q1Medicine (all)

Recommended pre-submission checks
Powered by 

Skin therapy letter Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | International Skin Therapy Newsletter, Inc. |
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in Skin therapy letter
A Review of the Long-Term Safety and Efficacy of Upadacitinib in the Treatment of Atopic Dermatitis.
- 1 Sep 2025
- Skin therapy letter
Therapeutic Advances in Neurofibromatosis Type 1: A Focus on Selumetinib.
- 1 Sep 2025
- Skin therapy letter
Nanodermatology
- 1 Jul 2025
- Skin therapy letter
Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
- 1 Jul 2025
- Skin therapy letter
A Novel Fixed Dose Triple Combination Therapy (IDP-126) for Moderate to Severe Acne.
- 1 May 2025
- Skin therapy letter
Use of Nemolizumab in the Treatment of Prurigo Nodularis and Atopic Dermatitis
- 1 May 2025
- Skin therapy letter
A Review of the Long-Term Safety and Efficacy of Upadacitinib in the Treatment of Atopic Dermatitis.
- 1 Sep 2025
- Skin therapy letter
Therapeutic Advances in Neurofibromatosis Type 1: A Focus on Selumetinib.
- 1 Sep 2025
- Skin therapy letter
Nanodermatology
- 1 Jul 2025
- Skin therapy letter
Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
- 1 Jul 2025
- Skin therapy letter
A Novel Fixed Dose Triple Combination Therapy (IDP-126) for Moderate to Severe Acne.
- 1 May 2025
- Skin therapy letter
Use of Nemolizumab in the Treatment of Prurigo Nodularis and Atopic Dermatitis
- 1 May 2025
- Skin therapy letter